Small Molecular Inhibitor of Transforming Growth Factor-β Protects Against Development of Radiation-Induced Lung Injury

SM16 at a dose of 0.15 g/kg reduced functional lung damage, morphologic changes, inflammatory response, and activation of TGF-β at 26 weeks after RT. The data suggest a dose response and also suggest the superiority of long-term vs. short-term dosing.